A study about the effect of Vitamin E on hyperlipidemia and atherosclerotic lesions in New Zealand white rabbits fed with a 1% cholesterol rich diet

Investigacion Clinica

Volumn 44, Issue 2, 2003, Pages 119-127

  Torres, Marysabel ^a,b   Márquez, Mercedes ^a   Sutil, Rosalía ^a   Carrizales, Maira ^a   Leal, María ^a   Reigosa, Aldo ^a  

^a UNIVERSIDAD DE CARABOBO   (Venezuela)

^b Torre A ^*  (Venezuela)

Author keywords

Atherosclerosis; Hyperlipidemia; New Zealand rabbits; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; KETAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HYPERLIPIDEMIA; MALE; NONHUMAN; RABBIT; RANDOMIZATION; VITAMIN SUPPLEMENTATION; ANIMAL; BLOOD; CHOLESTEROL INTAKE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; PATHOLOGY; TIME;

ANIMALS; ANTIOXIDANTS; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; HYPERLIPIDEMIAS; MALE; RABBITS; TIME FACTORS; VITAMIN E;

EID: 0141677791     PISSN: 05355133     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sharma N, Desigan B, Ghosh S, Sanyal SN, Ganguly NK, Majumdar S. Effect of antioxidant Vitamin E as a protective factor in experimental atherosclerosis in rhesus monkeys. Ann Nutr Metab 1999; 43(3):181-190.
2. El-Swefy S, Schaefer E J, Seman LJ, Van Dongen D, Sevanian A, Smith DE, Ordovas JM, El Swedy M and Meydani M. The effect of Vitamin E, probucol and lovastatina on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters. Atherosclerosis 2000; 149(2):277-286.
3. Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanism of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Cire Res 2000; 187(5):349-354.
4. Janero DR. Therapeutical potential of Vitamin E in the pathogenesis of spontaneous atherosclerosis. Free Radical Biol Med 1991; 11:129-144.
5. Schwenke DC, Behr SR. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations. Circ Res 1998 24; 83(4):366-377.
6. Guide for the care and use of animals. 1996. Institute of Laboratory Animal Resources. National Research Council. National Academy Press, Washington DC, USA.
7. Luna L. The Histological Staining Manual. Methods of the Armed Forces Institute of Pathology. 1968 Cap 1-4:11-37. Editions Mc Graw Hill. New York. USA.
8. Stary H, Blakley C, Dinsmore R, Fuster V, Glagov S, Insul W, Rosenfeld M, Schawartz C, Wagner W, Wissler R. A definition of advanced type of atherosclerotic lesions and histological classification of atherosclerosis. A report from the Committee on vascular lesions of council on Atherosclerosis American Heart Association. Atherioscler Thromb and Vasc Biol 1995; (9):1512-1531.
9. Bieri JG, Evarts RP. Gamma tocopherol: metabolism, biological activity and significance in human vitamin E nutrition. J Clin Nutr 1974; 27:980-986.
10. Gey KF. Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. Br Med Bull 1993; 49(3), 679-699.
11. Wiseman SA, Van Den Boom MAP, De Fouw NJ, Wassink MJ, Op Den Kamp JAF, Tuburg LBM. Comparison of the effects on dietary vitamin E on in vivo and in vitro parameters of lipid peroxidation in rabbits. Free Radical Biology & Medicine 1995; 19:5, 617-626.
12. Anderson TL, Matz J, Ferns GAA, Angaard EE. Vitamin E reverses cholesterol-induced endothelial dysfunction in the rabbit coronary circulation. Atherosclerosis 1994; 111:39-45.
13. Parker RA, Sabrah T, Cap M, Gill BT. Relation of vascular oxidative stress tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arterioscler Thromb Vasc Biol 1995; 15:349-358.
14. Schwenke DC, Behr SR. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations. Cir Res 1998; 24; 84(4):366-377.
15. Ismail NM, Abdul-Ghafar N, Jaarrin K, Khine JH, Top GM. Vitamin E and factors affecting atherosclerosis in rabbits fed cholesterol rich diet. Int J Food Sci Nutr 2000; 51(Suppl): S79-S94.
16. Paul A, Calleja L, Joven J, Vilella E, Ferre N, Capms J, Girona J, Osada J. Supplementation with Vitamin E and/or zinc does not atenúate atherosclerosis in apoliprotein E-deficient mice fed a high-fat, high-cholesterol diet. Int J Vitam Nutr Res 2001; 71(1):45-52.
17. Morel DW, De la Llera Moya M, Friday KE. Treatment of cholesterol-fed rabbits with dietary Vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis. J Nutr 1994; 124:2123-2130.
18. Djahansouzi S, Bresen JH, Koenig K, Beissiegel U, Kontush A. The effect of pharmacological doses of different antioxidants on oxidation parameters and atherogenesis in hyperlipidemic rabbits. Atherosclerosis 2001; 54(2):387-399
19. Kleinveld HA, Hak-Lemmers HLM, Hectors MPS, de Fouw NJ, Demacker PNM, Stalenhoef AFH. Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Artherioescler Thromb Vase Biol 1995; 15:290-297.
20. Chen L, Haught WH, Yang B, Saldeen TG, Parathasarathy S, Mehta JL. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanism of antiatherosclerotic effects of Vitamin E, lovastatin and amlodipine. J Am Coll Cardiol 1997; 30(2):569-575.
21. Prasad K, Kaira J. Oxygen free radicals and hypercholesterolemic atherosclerosis. Effect of Vitamin E. Am Heart J 1993; 125:958-973.
22. Stephens NG, Parsons A, Schofield PM. Randomized, controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347:781-786.
23. Losonezy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplementation use and risk of all-cause and coronary heart disease mortality in older persons: the established populations for epidemiological studies of the elderly. Am J Clin Nutr 1996; 52:557-563.
24. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patient at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J 1999, 20(10):725-741.
25. Brown G, Zhao X-Q, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ. Simvastatin and niacin, antioxidants vitamins, or the combination for the prevention of coronary disease. N Eng J Med 2001; 345:1583-1592.